NCT06638411

Brief Summary

This project has two aims. First, the research team will confirm whether providing a mental health awareness workshop poses unintended harms by raising the rate of self-diagnosis (as opposed to a neutral workshop) and causing worsening symptoms in previously healthy young adults over a period of one week. The study will focus on determining this in the context of ADHD, as it includes broad symptoms that overlap with normal experience, is commonly overdiagnosed, and is included in many awareness campaigns for neurodiversity and mental health. Second, the study will test whether nocebo effect education, or in other words, learning about the nocebo effects, during mental health awareness sessions "inoculates" against them. Simply learning about the role negative expectations play in creating side effects has been shown to reduce nocebo side effects of medications; perhaps, the same applies to mental health. Researchers will compare the outcome of the ADHD workshop with that of the same workshop but with nocebo information included; both experimental conditions will also be compared to an active control condition. Participants are hypothesised to report the following pattern of symptoms: ADHD information \> ADHD + nocebo education \> Control During the study participants will:

  1. 1.Randomize the participants to one of the three workshop conditions to watch
  2. 2.Report self-diagnosis score immediately after the workshop and 1 week later.
  3. 3.Report symptoms 1 week later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
215

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

October 16, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2024

Completed
Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

October 9, 2024

Last Update Submit

February 16, 2025

Conditions

Keywords

ADHDNocebo EffectMental Health Awareness

Outcome Measures

Primary Outcomes (2)

  • Self-reported ADHD symptoms

    As measured by Adult ADHD Self-Reported Symptom Scale (ASRS), a self-reported scale of ADHD symptoms with a score range of 0-72, with a higher score indicating worse symptoms.

    Change 1 week

  • Self-diagnosis with ADHD

    As measured by one item with a score range from 1 to 5, with a higher score indicating stronger self-diagnosing belief.

    Change: Immediate, 1 week

Secondary Outcomes (2)

  • Memory Failures

    Change, 1 week

  • Depressive and Anxiety Symptoms

    Change, 1 week

Study Arms (3)

ADHD information workshop

EXPERIMENTAL
Behavioral: ADHD information workshop

ADHD information workshop with nocebo education

EXPERIMENTAL
Behavioral: ADHD information workshop with nocebo education

Sleep and dreams workshop

ACTIVE COMPARATOR
Behavioral: Sleep workshop

Interventions

ADHD information workshop that will be delivered by a clinical psychology student in one 30-minute session to a group of participants. The workshop will present information about lesser-known or commonly misdiagnosed ADHD symptoms. To control for the duration of the nocebo module (see the condition below), participants will also learn about sleep and its relevance for maintenance of good cognitive health. At the end, the workshop will involve a writing reflection activity about personal experiences with ADHD symptoms.

ADHD information workshop

ADHD information workshop that will be delivered by a clinical psychology student in one 30-minute session to a group of participants. The workshop will present information about lesser-known or commonly misdiagnosed ADHD symptoms, together with a module on nocebo effects and their potential role in worsening symptoms. The nocebo module will describe the current understanding of the role of expectations in creating side effects and elaborate on how this applies to the field of mental health through a series of examples. It will also involve a writing reflection activity about personal experiences with ADHD symptoms, potential for nocebo effect when talking about ADHD symptoms, and ability to apply this information to personal experiences.

ADHD information workshop with nocebo education
Sleep workshopBEHAVIORAL

An information workshop about sleep and dream experiences that will be delivered by a clinical psychologist in one 30-minute session to a group of participants. It will be matched on duration, type of content, and engagingness with the experimental sessions.

Sleep and dreams workshop

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • No existing diagnosis of ADHD, or history/current diagnosis of any other neurological/psychiatric disorder.
  • Score below 18 on the Adult ADHD Self-Reported Symptom (ASRS) Checklist Screener.
  • No current intake of medication to treat a psychiatric disorder (e.g., antidepressants)
  • Fluent in English;
  • Access to a computer, tablet, or smartphone with internet capability;
  • Normal or corrected-to-normal vision and hearing.

You may not qualify if:

  • Diagnosis of ADHD or any other neurological/psychiatric disorder.
  • Active intake of medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Toronto

Toronto, Ontario, M1C 1A4, Canada

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants will be blinded to the study hypotheses and treatment arms, and to the type of intervention they are receiving. Outcome assessors will be blinded to participants' treatment arm assignment and the type of intervention they are receiving.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

October 16, 2024

Primary Completion

December 8, 2024

Study Completion

December 8, 2024

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Researchers will share anonymised data by depositing it in a data repository (e.g., Open Science Framework). We will also provide the statistical analysis plan for the data analysis.

Shared Documents
SAP

Locations